Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of February 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on February 14, 2019. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists solely of the cover page, signature block, and an exhibit index referencing a press release (Exhibit 99.1), but the content of the press release is not included in the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are present in the provided excerpt.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document references a press release as Exhibit 99.1, which may contain such information, but the text of that exhibit is not included in the source data.
Key Facts for Investor Verification
- The registrant is Hexindai Inc., not "Akso Health Group" as indicated in the request metadata.
- The filing date is February 14, 2019, covering the month of February 2019.
- Financial performance details are absent from this specific text; investors must locate and review Exhibit 99.1 (Press Release) for substantive data.
- The company files annual reports under Form 20-F.